A clinical trial evaluating an investigational medication for the treatment of PTSD (Posttraumatic Stress Disorder) in adults.
Have you experienced a traumatic event within the last 9 years?
Have you been diagnosed with PTSD as a result? If so, you may be eligible for a clinical trial.
Posttraumatic stress disorder (PTSD) is a psychiatric disorder that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, a serious accident, war/combat, or violent personal assault. People with PTSD have intense, disturbing thoughts and feelings related to their experience that last long after the traumatic event has ended. They may relive the event through flashbacks or nightmares; they may feel sadness, fear or anger; and they may feel detached from other people. People with PTSD may avoid situations or people that remind them of the traumatic event, and they may have strong negative reactions to something as ordinary as a loud noise or an accidental touch.
PTSD is diagnosed after a person experiences symptoms for at least one month following a traumatic event. However symptoms may not appear until several months or even years later. The disorder is characterized by three main types of symptoms:
- Re-experiencing the trauma through intrusive distressing recollections of the event, flashbacks, and nightmares.
- Emotional numbness and avoidance of places, people, and activities that are reminders of the trauma.
- Increased arousal such as difficulty sleeping and concentrating, feeling jumpy, and being easily irritated and angered.
IPS Research is seeking participants for a clinical trial of an investigational medication for the treatment of Posttraumatic Stress Disorder . If you have symptoms of PTSD, you may be a candidate for this clinical trial.
Qualified participants must meet the following requirements:
- Be 18 to 75 years of age
- Trauma event occured after age of 18 and within past 9 years
- PTSD symptoms causes distress or impairment in social, occupational, or other areas of life
Qualified participants may receive:
- Study-related care and study drug at no cost
- Compensation for time and travel